A5102914684- Breast Lesions and Carcinomas
- Breast Cancer Treatment Studies
- AI in cancer detection
- Digital Radiography and Breast Imaging
- MRI in cancer diagnosis
- Radiomics and Machine Learning in Medical Imaging
- Global Cancer Incidence and Screening
- Medical Imaging Techniques and Applications
- Cancer and Skin Lesions
- Radiology practices and education
- Hepatocellular Carcinoma Treatment and Prognosis
- Artificial Intelligence in Healthcare and Education
- COVID-19 and healthcare impacts
- Advanced X-ray and CT Imaging
- Salivary Gland Tumors Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Male Breast Health Studies
- Advanced MRI Techniques and Applications
- Cancer Diagnosis and Treatment
- Orthopedic Surgery and Rehabilitation
- Thyroid Cancer Diagnosis and Treatment
- Radiation Dose and Imaging
- Breast Implant and Reconstruction
- Ultrasound and Hyperthermia Applications
- Soft tissue tumor case studies
European Institute of Oncology
2012-2025
Istituti di Ricovero e Cura a Carattere Scientifico
1998-2025
Ripamonti
2017-2025
Ospedale Maggiore
1998
This study aims to evaluate the Average Glandular Dose (AGD) and diagnostic performance of CEM versus Digital Mammography (DM) as well DM plus one-view Breast Tomosynthesis (DBT), which were performed in same patients at short intervals time. A preventive screening examination high-risk asymptomatic between 2020 2022 was with two-view projections (Cranio Caudal Medio Lateral) one (DBT) projection (mediolateral oblique, MLO) a single session examination. For all whom we found suspicious...
Abstract Contrast-enhanced mammography (CEM) is a relatively recent diagnostic technique increasingly being utilized in clinical practice. Until recently, there was lack of standardized reporting for CEM findings. However, this has changed with the publication supplement Breast Imaging Reporting and Data System (BI-RADS). A comprehensive understanding essential further enhancing its role both screening managing patients breast malignancies. can also be beneficial problem-solving, improving...
Although breast cancer screening can benefit from Artificial Intelligence (AI), it is still unknown whether, to which extent or under conditions, the use of AI going be accepted by general population. The aim our study evaluate what females who are eligible for know about and how they perceive such innovation.We used a prospective survey consisting 11-multiple-choice questionnaire evaluating statistical associations with Chi-Square-test Fisher-exact-test. Multinomial-logistic-regression was...
Stereotactic Vacuum-Assisted Breast Biopsy Is Not a Therapeutic Procedure Even When All Mammographically Found Calcifications Are Removed: Analysis of 4,086 ProceduresSilvia Penco1, Stefania Rizzo2, Anna Carla Bozzini1, Antuono Latronico1, Simona Menna1, Enrico Cassano1 and Massimo Bellomi2 3Audio Available | Share
Objectives: We aimed to determine whether radiomic features extracted from a highly homogeneous database of breast MRI could non-invasively predict pathological complete responses (pCR) neoadjuvant chemotherapy (NACT) in patients with cancer. Methods: One hundred cancer receiving NACT single center (01/2017–06/2019) and undergoing were retrospectively evaluated. For each patient, within the biopsy-proven tumor on T1-weighted (T1-w) contrast-enhanced performed before NACT. The pCR was...
Abstract Purpose To compare the efficacy of contrast-enhanced spectral mammography, with ultrasound, full field digital mammography and magnetic resonance imaging in detection size estimation histologically proven breast tumors. Methods This open-label, single center, prospective study, included 160 dense women at least one suspicious mammary lesion evaluated by whom a tumor was after surgery performed European Institute Oncology between January 2013 December 2015. Following complete...
The following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget's Disease (PD) breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) cases where MRI is contraindicated inconclusive. Two clinical PD diagnosed at our Breast Division between January May 2024 were analyzed using CEM. These involved imaging techniques, including Digital (DM), Ultrasound (US), CEM, alongside...
Background: Breast reconstruction (BR) following mastectomy plays a critical role in restoring breast contour and improving patients’ quality of life. Acellular dermal matrices (ADMs) have emerged as valuable adjuncts BR, providing structural support enhancing soft tissue integration. However, their radiological characteristics remain underexplored, leading to potential misinterpretation diagnostic challenges. This study aims evaluate the imaging features ADM post-mastectomy patients using...
Background: To create a predictive score of malignancy breast lesion based on the main contrast enhancement features ascertained by contrast-enhanced spectral mammography (CESM). Methods: In this single-centre prospective study, patients with suspicious lesions (BIRADS > 3) were enrolled between January 2013 and February 2022. All participants underwent CESM prior to biopsy, eventually surgery. A radiologist 20 years’ experience in imaging evaluated presence or absence following descriptors:...
The study aimed to evaluate the performance of radiomics features and one ultrasound CAD (computer-aided diagnosis) in prediction malignancy a breast lesion detected with develop nomogram incorporating radiomic score available information on performance, conventional Breast Imaging Reporting Data System evaluation (BI-RADS), clinical information. 365 lesions referred for US subsequent histologic analysis between January 2020 March 2022 were retrospectively collected. Patients randomly...
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal hyperplasia (ADH) in situ or invasive carcinoma patients who underwent vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. (2) Methods: 2955 VABBs were reviewed; 141 with a diagnosis ADH selected for The association between patients’ characteristics cancer was evaluated both univariate multivariate analyses. (3) Results: rates (DCIS) (IC) were, respectively, 29.1% 7.8%. pooled DCIS IC...
To present an overview of the management male patients with Ductal Carcinoma In Situ breast (male DCIS).We retrospectively studied all a diagnosis pure DCIS from January 1999 to December 2018: 20 were identified in our cancer referral center. We collected data regarding clinical presentation, age onset, radiological features, receptor status neoplasm, histological type, and follow-up those patients.The median was 62 years (range 21-80). All underwent surgery, 15/20 (75%) cases mastectomy...